Health Care & Life Sciences » Pharmaceuticals | Jiangsu Kanion Pharmaceutical Co. Ltd.

Jiangsu Kanion Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,195
2,522
2,774
2,942
3,207
3,750
Cost of Goods Sold (COGS) incl. D&A
580
665
742
799
839
987
Gross Income
1,615
1,857
2,033
2,143
2,369
2,763
SG&A Expense
1,245
1,416
1,574
1,707
1,891
2,244
EBIT
362
430
443
432
476
518
Non Operating Income/Expense
2
4
5
12
5
12
Interest Expense
57
70
47
44
51
45
Pretax Income
347
373
419
429
439
496
Income Tax
46
49
54
53
61
58
Equity in Affiliates
-
-
-
-
-
-
Consolidated Net Income
301
323
365
376
378
438
Net Income
297
320
362
374
374
431
Net Income After Extraordinaries
297
320
362
374
374
431
Net Income Available to Common
297
320
362
374
374
431
EPS (Basic)
0.49
0.53
0.59
0.61
0.61
0.70
Basic Shares Outstanding
599
599
616
616
616
616
EPS (Diluted)
0.50
0.53
0.59
0.61
0.61
0.70
Diluted Shares Outstanding
599
599
616
616
616
616
EBITDA
426
520
552
571
630
679
Other Operating Expense
8
11
15
4
1
1
Non-Operating Interest Income
1
1
3
1
1
3
Minority Interest Expense
4
3
3
2
4
6

About Jiangsu Kanion Pharmaceutical Co.

View Profile
Address
Jiangning Industrial City
Lianyungang Jiangsu 222047
China
Employees -
Website http://www.kanion.com
Updated 07/08/2019
Jiangsu Kanion Pharmaceutical Co., Ltd. engages in the manufacture and sale of Chinese medicine pretreatment and extraction. It focuses on respiratory, gynecological, cardiovascular, and orthopedic disease. The company was founded on December 2, 2000 and is headquartered in Lianyungang, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.